SCHEMBL21783350

SCHEMBL21783350

[O-][S+](Nc1cscn1)c1cnc(NCc2ccccc2F)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 16/20 0.44
SCN8A Q9UQD0 16/20 0.44
SCN5A Q14524 15/20 0.44
SCN1B Q07699 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
ATM Q13315 1/20 0.37
PLA2G1B P04054 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
NR1I2 O75469 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783448 0.90 SCN8A (0.42) SCN1ASCN8ASCN5ASCN1BMEN1
SCHEMBL21783325 0.76 CASP6 (0.44) SCN1ASCN8ASCN5ASCN1BL3MBTL1
SCHEMBL21783441 0.68 SCN8A (0.43) SCN1ASCN8ASCN5ASCN1BMEN1
SCHEMBL20256561 0.68 SCN8A (0.43) SCN1ASCN8ASCN5ASCN1BNR1I2
SCHEMBL20256512 0.67 SCN8A (0.50) SCN1ASCN8ASCN5ASCN1BNR1I2
SCHEMBL21783342 0.67 SCN8A (0.38) SCN1ASCN8ASCN5ASCN1BMEN1
SCHEMBL20256423 0.65 SCN1A (0.66) SCN1ASCN8ASCN5A
SCHEMBL20256732 0.63 SCN8A (0.43) SCN1ASCN8ASCN5ASCN1BNR1I2
SCHEMBL20256604 0.63 SCN8A (0.50) SCN1ASCN8ASCN5ASCN1BNR1I2
SCHEMBL20256695 0.63 SCN8A (0.78) SCN1ASCN8ASCN5ASCN1BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047323-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed